These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 11597097)

  • 1. Nogo: a molecular determinant of axonal growth and regeneration.
    Grandpré T; Strittmatter SM
    Neuroscientist; 2001 Oct; 7(5):377-86. PubMed ID: 11597097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular mechanism and regulation of axon growth inhibition].
    Yamashita T
    Brain Nerve; 2007 Dec; 59(12):1347-53. PubMed ID: 18095484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin-associated inhibitors of axon regeneration.
    Grados-Munro EM; Fournier AE
    J Neurosci Res; 2003 Nov; 74(4):479-85. PubMed ID: 14598291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nogo and the Nogo-66 receptor.
    Fournier AE; GrandPré T; Gould G; Wang X; Strittmatter SM
    Prog Brain Res; 2002; 137():361-9. PubMed ID: 12440378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
    McGee AW; Strittmatter SM
    Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein.
    GrandPré T; Nakamura F; Vartanian T; Strittmatter SM
    Nature; 2000 Jan; 403(6768):439-44. PubMed ID: 10667797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats.
    Lenzlinger PM; Shimizu S; Marklund N; Thompson HJ; Schwab ME; Saatman KE; Hoover RC; Bareyre FM; Motta M; Luginbuhl A; Pape R; Clouse AK; Morganti-Kossmann C; McIntosh TK
    Neuroscience; 2005; 134(3):1047-56. PubMed ID: 15979242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury.
    Pot C; Simonen M; Weinmann O; Schnell L; Christ F; Stoeckle S; Berger P; Rülicke T; Suter U; Schwab ME
    J Cell Biol; 2002 Oct; 159(1):29-35. PubMed ID: 12379801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nogo and axon regeneration.
    Schwab ME
    Curr Opin Neurobiol; 2004 Feb; 14(1):118-24. PubMed ID: 15018947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system.
    Buchli AD; Schwab ME
    Ann Med; 2005; 37(8):556-67. PubMed ID: 16338758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.
    Giger RJ; Venkatesh K; Chivatakarn O; Raiker SJ; Robak L; Hofer T; Lee H; Rader C
    Restor Neurol Neurosci; 2008; 26(2-3):97-115. PubMed ID: 18820405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
    Hunt D; Coffin RS; Anderson PN
    J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
    Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNS axon regeneration inhibitors stimulate an immediate early gene response via MAP kinase-SRF signaling.
    Stern S; Knöll B
    Mol Brain; 2014 Nov; 7():86. PubMed ID: 25406759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of Nogo-A by collagen scaffolds impregnated with bone marrow stromal cell treatment after traumatic brain injury promotes axonal regeneration in rats.
    Mahmood A; Wu H; Qu C; Mahmood S; Xiong Y; Kaplan D; Chopp M
    Brain Res; 2014 Jan; 1542():41-8. PubMed ID: 24177046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of PTEN and Nogo Codeletion on Corticospinal Axon Sprouting and Regeneration in Mice.
    Geoffroy CG; Lorenzana AO; Kwan JP; Lin K; Ghassemi O; Ma A; Xu N; Creger D; Liu K; He Z; Zheng B
    J Neurosci; 2015 Apr; 35(16):6413-28. PubMed ID: 25904793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.
    Chen MS; Huber AB; van der Haar ME; Frank M; Schnell L; Spillmann AA; Christ F; Schwab ME
    Nature; 2000 Jan; 403(6768):434-9. PubMed ID: 10667796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Nogo-A in axonal plasticity, regrowth and repair.
    Pernet V; Schwab ME
    Cell Tissue Res; 2012 Jul; 349(1):97-104. PubMed ID: 22588543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration.
    Peng X; Zhou Z; Hu J; Fink DJ; Mata M
    J Biol Chem; 2010 Jan; 285(4):2783-95. PubMed ID: 19901030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.